Cognitive functioning disrupts after receiving chemotherapy as a treatment for breast cancer, said researchers at the University Hospital Gasthuisberg of the Katholieke Universiteit Leuven in Belgium. They are now trying to find the reason behind why cognitive decline occurs in patients after being treated with chemotherapy. The details of the study have been published in a new report this week in the Journal of Clinical Oncology.
Cancer patients have been found to experience decline in cognitive performance following chemotherapy and also after no chemotherapy, said Deprez, lead author on the paper. Not being able to do multitasking is the major problem cancer patients suffer after going through rounds of chemotherapy.